Skip to main content
SpringerLink
Log in
Book cover

Inflammatory Bowel Diseases 1990 pp 235–241Cite as

Immunosuppressive Drugs: Do they have Any Role in the Treatment of IBD?

(B)

  • Chapter

  • 54 Accesses

Part of the book series: Developments in Gastroenterology ((DIGA,volume 11))

Abstract

The immune system seems to be involved in the pathogenesis of IBD although the mechanisms are unknown. Certainly the immune system shows evidence of activation during exacerbations of disease. Based on these considerations, immunosuppressive agents have been given empirically to patients with IBD.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lennard-Jones, J.E., and Singleton, J.W.: The azathioprine controversy. Dig.Dis. Sci. 26:364, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Korelitz, B.I.: The role of immunosuppressives. Mt. Sinai J. Med. 50:144, 1983.

    PubMed  CAS  Google Scholar 

  3. Korelitz, B.I.: Pharmacotherapy of inflammatory bowel disease. Postgrad. Med. 74:165, 1983.

    PubMed  CAS  Google Scholar 

  4. Sturdevant, R.A.L., et.al.: Azathioprine-related pancreatitis in patients with Crohn’s disease. Gastroenterology 77:883, 1979.

    PubMed  CAS  Google Scholar 

  5. Anonymous: Azathioprine and 6-mercaptopurine for Crohn’s disease. Lancet 2:298, 1980.

    Google Scholar 

  6. Willoughby, J.M.T., et al: Controlled trial of azathioprine in Crohn’s disease. Lancet 2:944, 1971.

    Article  PubMed  CAS  Google Scholar 

  7. Rhodes, J., et al: Controlled trial of azathioprine in Crohn’s disease. Lancet 2:1273, 1971.

    Article  PubMed  CAS  Google Scholar 

  8. Klein, M., et al: Treatment of Crohn’s disease with azathioprine: A controlled evaluation. Gastroenterology 66:916, 1974.

    PubMed  CAS  Google Scholar 

  9. Rosenberg, J.L. et al: A controlled trial of azathioprine in Crohn’s disease. Am. J. Dig. Dis. 20:721, 1975.

    Article  PubMed  CAS  Google Scholar 

  10. Present, D.H. et al: Treatment of Crohn’s disease with 6-mercaptopurine: A long-term, randomized, double-blind study. N. Eng. J. Med. 302:981, 1980.

    Article  CAS  Google Scholar 

  11. O’Donoghue, D.P. et al: Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn’s disease. Lancet 2:955, 1978.

    Article  PubMed  Google Scholar 

  12. Korelitz, B.I. and Present, D.H.: Favorable effect of 6-mercaptopurine on fistulae of Crohn’s disease. Dig. Dis. Sci. 30:58, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Korelitz, B.I. and Present, D.H.: Shortcomings of the National Crohn’s Disease Study: The exclusion of azathioprine without adequate trial (letter). Gastroenterology 80:193, 1981.

    PubMed  CAS  Google Scholar 

  14. Present, D., Meltzer S.J., Wolke, A. and Korelitz, B.I.: Short and long term toxicity to 6-mercaptopurine in the management of inflammatory bowel disease. Gastroenterology 88:1545, 1985.

    Google Scholar 

  15. Kinlen, L.J., Sheil, A.G.R., Peto, J. and Doll, R.: Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br. Med. J. 2:1461, 1979.

    Article  PubMed  CAS  Google Scholar 

  16. Allison, M.C. and Pounder, R.E.: Cyclosporin for Crohn’s disease (letter). Lancet 1:902, 1984.

    Article  PubMed  CAS  Google Scholar 

  17. Bianchi, P.A., Mondelli, M., Quarto di Palo, F. and Ranzie, T.: Cyclosporin for Crohn’s disease (letter). Lancet 1:1241, 1984.

    Google Scholar 

  18. Allan, R.N.: Medical management: its accomplishments in Crohn’s disease and indications for surgery. World J. Surg. 12(2):174–9, 1988.

    Article  PubMed  CAS  Google Scholar 

  19. Goldstein, F.: Immunosuppressant therapy of inflammatory bowel disease. Pharmacologic and clinical aspects. J. Clin. Gastroent. 9(6):654–8, 1987.

    Article  PubMed  CAS  Google Scholar 

  20. Nyman, M., Hansson, L, and Eriksson, S.: Long term immunosuppressive treatment in Crohn’s disease. Scan. J. Gastroent. 20(10):1197–203, 1985.

    CAS  Google Scholar 

  21. Meyers, S., Walfish, J.S., Sachar, D.B., et al: Quality of life after surgery for Crohn’s disease: A psychosocial survey. Gastroenterology 78:1–6, 1980.

    PubMed  CAS  Google Scholar 

  22. Agrez, M.V., Valente, R.M., Pierce, W., et al: Surgical history of Crohn’s disease in a well-defined population. Mayo Clin. Proc. 57:747–52, 1982.

    PubMed  CAS  Google Scholar 

  23. Binder, V., Hendriksen, C. and Kreiner, S.: Prognosis in Crohn’s disease — based on results from a regional patient group from the county of Copenhagen. Gut 26:146–50, 1985.

    Article  PubMed  CAS  Google Scholar 

  24. Singleton, J.W.: Azathioprine has a very limited role in the treatment of Crohn’s disease. Dig. Dis. Sci. 26(4):368–71, 1981.

    Article  PubMed  CAS  Google Scholar 

  25. Penn, L: Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492–502, 1978.

    PubMed  CAS  Google Scholar 

  26. Trinka, W.M., Glotzer, D.J., Kasdon, E.J. et al: The long-term outcome of restorative operation in Crohn’s disease. Ann. Surg. 196:345–55, 1982.

    Article  Google Scholar 

  27. Greenstein, A.J., Sachar, D.B., Pasternack, B.S. and Janowitz, H.D.: Reoperation and recurrence in Crohn’s colitis and ileocolitis. New Eng. J. Med. 293:685–90, 1975.

    Article  PubMed  CAS  Google Scholar 

  28. Lennard-Jones, J.E. and Stalder, G.A.: Prognosis after resection of chronic regional ileitis. Gut 8:332–6, 1967.

    Article  PubMed  CAS  Google Scholar 

  29. Kinlen, L.J.: Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am. J. Med. 78:44–49, 1985.

    Article  PubMed  CAS  Google Scholar 

  30. Greenstein, A.J., Gennuso, R., Sachar, D.B., et al: Extraintestinal cancers in inflammatory bowel disease. Cancer 56:2914–21, 1985.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of Alabama at Birmingham, UAB Station, Birmingham, AL, 35294, USA

    Charles O. Elson M.D.

Authors
  1. Charles O. Elson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, Hadassah University Hospital, Mount Scopus, Jerusalem, Israel

    D. Rachmilewitz  & J. Zimmerman  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Elson, C.O. (1990). Immunosuppressive Drugs: Do they have Any Role in the Treatment of IBD?. In: Rachmilewitz, D., Zimmerman, J. (eds) Inflammatory Bowel Diseases 1990. Developments in Gastroenterology, vol 11. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1980-8_25

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1980-8_25

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7385-1

  • Online ISBN: 978-94-009-1980-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation